Zhengye Biotechnology Holding Limited Announces Fiscal Year 2024 Financial Results
Provided By PR Newswire
Last update: Jul 3, 2025
JILIN, China, July 3, 2025 /PRNewswire/ -- Zhengye Biotechnology Holding Limited (Nasdaq: ZYBT) (the "Company" or "Zhengye"), a veterinary vaccine manufacturer that encompasses research, development, manufacturing, and sales of veterinary vaccines, with a focus on livestock vaccines in China, today announced its financial results for the fiscal year ended December 31, 2024.
Read more at prnewswire.com
